Ark Surgical Overview
Ark Surgical is a commercial-stage medical device company focused on advancing women’s health through safer, smarter surgical solutions. The company has successfully addressed a critical unmet need identified by the FDA and now offers two FDA-cleared devices in the U.S. market. Its flagship product, LapBox, is a first-of-its-kind containment system that enables minimally invasive and robotic gynecologic surgeries while preventing the spread of cancerous or endometrial tissue—a risk highlighted by the FDA. Ark Surgical’s technology empowers gynecologic surgeons to optimize outcomes and patient safety while helping hospitals meet FDA compliance standards for tissue containment.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
/PRNewswire/ -- Ark Surgical, a women's health-focused medical device innovator, has received FDA 510(k) clearance for LapBox® POWER, a breakthrough tissue...
Ark Surgical, a company focused on womens health, has received FDA 510(k) clearance for its LapBox® POWER, a tissue containment system for use with power morcellators in minimally invasive gynecologic surgery. This clearance expands on their 2023 approval for manual morcellation, making LapBox® the first FDA-cleared dual-wall containment system for both manual and power tissue extraction. The system, designed in collaboration with OB/GYNs, aims to prevent the spread of undiagnosed cancer and other harmful tissues during laparoscopic procedures. The FDA has emphasized the importance of using cleared containment systems to mitigate risks associated with uncontained morcellation. With a large number of gynecologic procedures performed annually, Ark Surgicals innovation supports safer surgeries, benefiting both patients and providers.
FDA approved/pending approval
growth-positive
Ark Surgical Secures $1.1M in Funding to Advance Safer Surgical Solutions for Women's Health -
Ark Surgical, a medical device company focused on womens health, has secured an additional $1.1 million in funding between December 2023 and January 2024. The investment will support the U.S. market expansion of its FDA-cleared tissue containment system, the LapBox. The funding round included participation from Intempo Ventures, NGT3, the Israel Innovation Authority, and the Israel Ministry of Economy and Industry, as well as a U.S.-based medical device group. The LapBox is designed to facilitate safer surgical procedures for women, particularly hysterectomies, by preventing the dispersion of cancerous tissues. Ark Surgical is now preparing to scale its commercial activities in the U.S. and is seeking strategic distribution partners.
InvestmentPartners
growth-positive
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation |
Ark Surgical, an Israeli medical device company, has announced the successful completion of its first hysterectomy procedures in the US using the LapBox tissue containment system for manual morcellation. The LapBox system is designed to improve patient outcomes and lower the risk of cancer cell spread during minimally invasive hysterectomies. The FDA-cleared device is now available in the US. The Arizona Gynecology Consultants were among the first to use the LapBox system.
CustomersPartners
growth-positive
Novel Tissue Containment System for Manual Morcellation Lowers Risk of Cancer Cell Spread
Ark Surgical, based in Nazareth, Israel, has received FDA clearance for its LapBox containment removal system, designed to facilitate safe tissue removal during laparoscopic surgeries. The LapBox aims to reduce the risks associated with open surgeries and uncontained morcellation, particularly for procedures like hysterectomies and myomectomies. The device features a double-walled design that minimizes the spread of cancerous cells and enhances surgical precision. This development is expected to positively impact Ark Surgical by providing gynecologists with a safer and more efficient tool for tissue removal.
Customers
growth-positive
Israeli Femtech Start-up, Ark Surgical, secures $2.1 Million in Funding for LapBox Tissue Containment System for Laparoscopic GYN Surgery
Ark Surgical Ltd., an Israeli Femtech start-up, has secured $2.1 million in funding for its LapBox containment system, which is used for the secure removal of large internal organs during laparoscopic GYN surgery. The funding was raised from investors of the Together equity crowdfunding platform, the Israeli Innovation Authority, and NGT. The company has completed the first-in-human study demonstrating the safety and functionality of the LapBox. The current funding will enable Ark Surgical to submit for FDA regulatory and marketing clearance.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $7.11M |
| Last funding | $850K |
| Stage | A |
| Rounds | 14 |
| Investors | 1 |
Team Members
7
Employees: 11-50
Web & Social Links
| Website | www.ark-surgical.com |
Locations
Wadi el-Haj Street 13, Nazareth, Israel
Photos & Videos
3 item(s)
